Total Funding
63
44
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
152701
develops an antimicrobial air treatment technology that kills 98% of the SARS-CoV-2 virus in the air.
About the Company
Bleu Garde™, LLC is an emerging leader in developing next-generation indoor air treatment solutions for disease mitigation, indoor air quality, and pandemic response. In 2021, the EPA awarded the Company the Agency’s first-ever emergency exemption for an airborne antiviral effective at eliminating the SARS-CoV-2 virus in the air.
The Company’s
proprietary, patented technology is the foundation for its first EPA registration, for mold odor elimination and prevention, and for its unique air treatment solution which, pending final EPA registration, will be effective and safe for use in all indoor occupied spaces for the elimination of airborne pathogens.
